Abbott Laboratories buy Freedom Capital
Start price
31.01.26
/
50%
€92.30
Target price
31.01.27
-
Performance (%)
-4.10%
Price
10:33
€88.52
Summary
This prediction is currently active. With a performance of -4.10%, the BUY prediction for Abbott Laboratories by Freedom_Capital is down slightly. This prediction currently runs until 31.01.27. The prediction end date can be changed by Freedom_Capital at any time. Freedom_Capital has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Abbott Laboratories | -1.295% | -1.295% |
| iShares Core DAX® | 4.852% | -2.747% |
| iShares Nasdaq 100 | 3.999% | -3.330% |
| iShares Nikkei 225® | 4.221% | -2.912% |
| iShares S&P 500 | 3.324% | -2.954% |
Comments by Freedom_Capital for this prediction
In the thread Discuss Abbott Laboratories
Abbott Laboratories (NYSE:ABT) was upgraded by analysts at Freedom Capital from a "hold" rating to a "strong-buy" rating.
Ratings data for ABT provided by MarketBeat